Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. (Record no. 27109157)

MARC details
000 -LEADER
fixed length control field 02385 a2200649 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517151632.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201708s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-5488
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1470-2045(17)30279-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Coleman, Robert L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170824
245 00 - TITLE STATEMENT
Title Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Oncology
Date of publication, distribution, etc. 06 2017
300 ## - PHYSICAL DESCRIPTION
Extent 779-791 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carboplatin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Ovarian Epithelial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytoreduction Surgical Procedures
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fallopian Tube Neoplasms
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms, Glandular and Epithelial
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paclitaxel
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peritoneal Neoplasms
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brady, Mark F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Herzog, Thomas J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sabbatini, Paul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Armstrong, Deborah K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Walker, Joan L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kim, Byoung-Gie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fujiwara, Keiichi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tewari, Krishnansu S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Malley, David M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davidson, Susan A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rubin, Stephen C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name DiSilvestro, Paul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Basen-Engquist, Karen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Helen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chan, John K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spirtos, Nick M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ashfaq, Raheela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mannel, Robert S
773 0# - HOST ITEM ENTRY
Title The Lancet. Oncology
Related parts vol. 18
-- no. 6
-- p. 779-791
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1470-2045(17)30279-6">https://doi.org/10.1016/S1470-2045(17)30279-6</a>
Public note Available from publisher's website

No items available.